Medovex Corporation Launches New Corporate and Investor Relations Website

ATLANTA, GA--(Marketwired - Feb 17, 2015) - Medovex Corp. (NASDAQ: MDVX), a developer of medical technology products including the DenerveX™ device, today launched its new corporate and investor relations website at www.medovex.com.

The new IR section of the company's website features real time posting of the company's press releases, as well as the automated posting of all of the company's public filings. The site also provides investors with an IR calendar featuring potential upcoming events, conference calls, investor presentations, CEO interviews and media coverage, in addition to corporate videos and a frequently asked questions section.

Investors are encouraged to sign up for real time alerts at: http://ir.medovex.com/email-alerts

Jarrett Gorlin, CEO of Medovex Corporation stated, "I have long believed corporate transparency and accountability are foundational to creating shareholder value. In an effort to facilitate both, we are pleased to have launched a user friendly and investor centric site with dynamic content where investors can find relevant company information, as well as allowing them to opt in to receive certain real time email alerts."

About Medovex:

Medovex was formed to acquire and develop a diversified portfolio of potentially ground breaking medical technology products. Criteria for selection include those products with potential for significant improvement in the quality of patient care combined with cost effectiveness. The Company's first pipeline product, the DenerveX device, is intended to provide long lasting relief from pain associated with facet joint syndrome at significantly less cost than currently available options. To learn more about Medovex Corp., visit www.medovex.com

Safe Harbor Statement:

Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.